🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

EXEL EXEL

Company Profile ↓
$56.70
+54.03% 1Y
P/E20.40
52W High$57.10
52W Low$34.54
EPS (TTM)$2.78

Company Overview

EXEL (EXEL) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 36.2%, reflecting efficient use of shareholder capital.

Healthy Capital Returns

Return on capital employed stands at 35.8%.

Consistent Profit Growth

Net profit has compounded at 47.6% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 17.4% CAGR over the past five years.

Healthy Margins

Maintains a net profit margin of 33.7%.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Jan 2026 Revenue of $2.32B (+7.0% YoY); net profit $782.57M.
  • Trailing 12 Months Year-on-year growth — revenue +7.0%, earnings +50.1%.
  • 5-Year Trend Long-term compounding — revenue CAGR 17.4%, profit CAGR 47.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:17.40%
1 Year:6.98%

Compounded Profit Growth

5 Years:47.58%
1 Year:50.13%

Stock Price Performance

1 Year:+54.03%
6 Months:+33.13%
3 Months:+27.65%
1 Month:-0.67%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 98% of range
$34.54 $57.10
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)57.00 · Neutral
Price Performance
1M-0.67%
3M+27.65%
6M+33.13%
1Y+54.03%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Strong return on equity of 36.2%.
  • Healthy ROCE of 35.8%.
  • Excellent profit margin of 33.7%.
  • Compounding revenue at 17.4% over 5 years.
  • Profit CAGR of 47.6% over 5 years.
  • Generates positive free cash flow.

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
20.40
Industry PE
-
Forward P/E est.
13.59
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
17.40%
Profit 5Y
47.58%
Revenue (YoY)
6.98%
Earnings (YoY)
50.13%

Profitability & Returns

ROCE
35.76%
ROE
36.21%
ROA
27.51%
Profit Margin
33.73%
Op Margin
37.59%
Gross Margin
-
EPS (Latest Qtr)
$0.79
EPS (TTM)
$2.78

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$2.59B
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
1.82%
Chg in Prom Hold
-
FII / Inst Holding
106.50%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$2.32B
EBITDA
-
Free Cash Flow
$875.84M
Operating Cash Flow
$884.27M
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2015Dec 2015Mar 2016Apr 2016Jun 2016Jul 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Jan 2020Apr 2020Jul 2020Oct 2020Jan 2021Apr 2021Jul 2021Oct 2021Apr 2022Jul 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Apr 2025Jul 2025Oct 2025Apr 2026
Revenue --------80.89M99.01M152.51M120.07M213.72M186.11M225.40M228.60M215.49M240.28M271.70M240.31M226.91M259.48M231.09M270.05M270.23M385.18M328.42M355.98M419.43M411.74M408.79M469.85M471.92M425.23M637.18M539.54M555.45M568.26M597.75M610.81M
Gross Profit 8.43M8.91M8.41M8.41M30.06M30.06M40.29M50.06M65.67M84.99M91.76M91.52M128.63M139.84M155.59M168.87M172.08M186.14M184.23M184.41M184.59M169.51M159.86M191.32M----------------
Operating Income -35.78M-31.60M-49.13M-49.13M-25.14M-25.14M7.26M38.88M20.19M27.11M81.18M37.43M116.31M85.77M125.18M111.60M84.56M91.99M115.61M77.32M52.81M75.53M-42.58M24.30M-4.61M123.01M51.62M83.24M83.71M82.61M28.83M77.85M-17.58M29.46M275.87M136.07M186.86M213.58M236.54M251.34M
Net Income -45.54M-41.57M-59.22M-59.22M-34.84M-34.84M-11.28M35.12M16.70M17.66M81.38M38.49M115.86M87.49M126.63M360.09M75.78M79.04M97.45M68.74M48.61M66.82M-32.04M28.39M1.60M96.09M38.20M68.57M70.67M73.21M40.03M81.18M1.04M37.32M226.12M117.97M159.62M184.85M193.58M210.47M
Diluted EPS ---0.26-0.26-0.15-0.15-0.040.120.050.060.260.120.370.280.411.150.240.250.310.220.150.21-0.100.090.000.300.120.210.220.230.120.250.000.120.770.400.550.650.690.79
R&D Expense 26.09M-28.93M-22.98M-20.26M-23.21M28.21M28.54M-37.76M42.49M44.74M-63.29M81.93M97.30M-101.88M114.93M176.76M-159.29M148.79M163.37M156.67M199.48M198.84M234.25M232.57M332.58M227.69M211.15M222.57M212.23M200.36M199.16M199.92M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Jan 2016Dec 2016Dec 2017Dec 2018Jan 2020Jan 2021Dec 2021Dec 2022Dec 2023Jan 2025Jan 2026
Revenue 151.76M185.04M289.64M47.45M31.34M25.11M37.17M37.17M191.45M452.48M853.83M967.77M987.54M1.43B1.61B1.83B2.17B2.32B
Operating Income -121.91M-91.40M89.53M-122.44M-200.73M-224.46M-121.42M-121.42M-28.12M165.91M438.86M369.47M110.06M286.67M201.48M170.88M604.62M872.19M
Net Income -135.22M-92.33M75.70M-145.34M-238.19M-261.30M-161.74M-161.74M-70.22M154.23M690.07M321.01M111.78M231.06M182.28M207.76M521.27M782.57M
Diluted EPS -1.26-0.850.58-0.92-1.33---0.77-0.280.492.211.020.350.720.560.651.762.78
R&D Expense 234.70M210.68M156.84M128.88M178.76M189.10M96.35M96.35M95.97M112.17M182.26M336.96M547.85M693.72M891.81M1.04B910.41M825.00M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Jan 2015Dec 2015Jan 2016Dec 2016Dec 2017Dec 2018Jan 2020Jan 2021Dec 2021Dec 2022Dec 2023Jan 2025Jan 2026
Total Assets --360.79M393.26M721.10M503.29M323.27M-332.34M-595.74M655.29M1.42B1.89B2.14B2.62B3.07B2.94B2.95B2.84B
Total Equity -56.26M-163.72M-228.32M90.63M238.13M14.50M-159.32M-159.32M-140.81M-140.81M89.32M284.96M1.29B1.69B1.88B2.21B2.49B2.26B2.24B2.16B
Cash & Equivalents 247.70M86.80M97.44M74.26M170.07M103.98M80.39M80.39M141.63M141.63M151.69M183.16M314.77M266.50M319.22M647.17M501.19M262.99M217.37M482.49M
Long Term Debt --170.71M176.65M322.57M335.48M259.13M-417.94M-00--------
Total Liabilities --589.12M302.63M476.01M483.45M482.59M-473.15M-506.42M370.33M134.83M199.70M258.22M405.62M583.06M678.45M703.49M683.10M
Current Liabilities --199.94M92.33M81.70M87.85M170.43M-52.25M-268.79M115.17M105.47M142.75M204.66M337.59M324.36M394.28M403.77M405.64M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Jan 2016Dec 2016Dec 2017Dec 2018Jan 2020Jan 2021Dec 2021Dec 2022Dec 2023Jan 2025Jan 2026
Operating Cash Flow -14.59M-101.05M-159.23M-123.15M-198.77M-235.41M-141.59M-141.05M210.40M165.61M415.72M526.96M208.98M400.80M362.61M333.32M699.97M884.27M
Investing Cash Flow -112.32M-19.57M-51.46M-259.47M144.35M146.33M50.08M50.08M-214.55M36.80M-297.85M-587.25M-131.22M-42.88M-524.41M-26.95M-116.78M350.44M
Financing Cash Flow -33.99M131.26M187.51M478.43M-11.67M65.49M152.75M152.21M15.70M-169.93M9.69M12.55M-25.13M-14.80M586.00K-546.05M-628.81M-969.59M
Capital Expenditure -5.91M-1.81M-991.00K-2.72M-2.17M-474.00K-447.00K-447.00K-1.70M-21.14M-33.30M-12.83M-30.34M-54.23M-27.71M-40.47M-28.43M-8.43M
Free Cash Flow -20.50M-102.86M-160.22M-125.86M-200.94M-235.88M-142.03M-141.50M208.70M144.47M382.42M514.12M178.64M346.58M334.91M292.86M671.54M875.84M
Share Buybacks -------------00550.38M652.03M947.51M

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Jan 2016Dec 2016Dec 2017Dec 2018Jan 2020Jan 2021Dec 2021Dec 2022Dec 2023Jan 2025Jan 2026
Gross Margin % ------------------
Operating Margin % -80.3%-49.4%30.9%-258.0%-640.5%-893.9%-326.6%-326.6%-14.7%36.7%51.4%38.2%11.1%20.0%12.5%9.3%27.9%37.6%
Net Margin % -89.1%-49.9%26.1%-306.3%-760.1%-1,040.6%-435.1%-435.1%-36.7%34.1%80.8%33.2%11.3%16.1%11.3%11.4%24.0%33.7%
ROE % 82.6%40.4%83.5%-61.0%-1,642.9%164.0%114.9%114.9%-78.6%54.1%53.6%19.0%5.9%10.5%7.3%9.2%23.2%36.2%
ROCE % --56.8%29.8%-19.1%-48.3%-146.9%-43.4%--8.6%30.7%33.3%21.2%5.7%12.6%7.3%6.7%23.8%35.8%

Shareholding Pattern

Insiders
1.82%
Institutions
106.50%
Public Float
108.47%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for EXEL

Google News Wed, 05 Aug 2026

Exelixis (EXEL) Stock Still Looks Cheap On Earnings While Returns Look Rich - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxQSTFMdWJpQ0VleDB6bXpvcWgwRXpJcVBDS0VTMkZSZF9FNEZBMG9jZF9sSVpHdk44S0wtenp6RWZ3YXB1WEdjQjJIcG1HRnpDVERtUTVQYVFVbmhjNEpVWkdKakxhakZ5ak9IX1lnY0FpV0ZjT3dDcDNJeWpiNDJma3hTM2hEUVJYS2FfYl…

Google News Mon, 20 Jul 2026

Exelixis (EXEL) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQOG5kX2JLY2cwdy14ZGs3LTAtenNoaDQ3ekZpeHZHZ0J1enJVNF9QS0d5UU1vcnlVUHgxdnlHOXdKRTFiVWY0ME5OS054cFFUN19Oa0lBa2V5cTFqdm9NM1laTU5KYXYzX0xObUpkZjZabGo3VDNRQXdmYmZsdUpyWVFES1hLUU5hck5Ncj…

Google News Fri, 31 Jul 2026

Exelixis (EXEL) Slides as Investors Likely Take Profits Ahead of Earnings - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQc2JVaWo4UWRuZXRubmRnb3M2OTdQLTJJblZsc280M2FISDQ1NjdURWRwc3NjVGM0dTVRQjNncG1TUWFySEdWbFhHeU9QXzBTVU5seXg5QlJkSnI4Tjl6czFfMmJrMDZkUFZtSXU4X1Y3WUZIRXhjekRxd0JFZlBMaFZoS0RlbnQxR2RRem…

Google News hu, 21 May 2026

Is Exelixis Stock Utilizing Systematic Share Retirement for Long-Term Alpha? - Trefis

<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxNTkZ1WVozUXMyVGlfZkJJQWhOTDNxVkdIMm9Hamo4ckt0bnc1QnhCNVpPMUhSYUVwdy1reUI3UFBaVTF0VkVuNkQwUzh4WUpsc2JiQktWeVBsRUlpdDhGbDFmZE9pNUFBVVVNVmk4YmF4WlBqbzZJRFpUTXBWWGN6M0FsYVQzX0I4eXZxR0…

Google News Wed, 22 Jul 2026

Exelixis sets Aug. 5 webcast to discuss Q2 results and update - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPRGRrMHBEWHNjVHl5bmZHNDF6MDdYVkZIUktfWFlXajFQMHBjbjR0Q3RvVmFVY3RIOEZ6bUREQWxyTjk5WUNLU0pab2gySENJS19BWXVfVWhjaXF1aUxWOVNObWZnS1ZLZ20wZHNiczJCdUxYMlEtZmxIY3lvTkg5SzJBbll1Q3dKeTEtaE…

Google News Mon, 03 Aug 2026

Exelixis stock rating maintained at Market Outperform by Citizens - Investing.com

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxOYzd3V0hhZkE1eVo3aU1nSlN5UTdpSkJCVWNUdmpHUFlYdDVrLVRRQS1Mak9wQ016RnFCSzk0VTlNZVVObk54Y2xEUlVOM0hON3JpSW5zREZ6T0ppdHN4REFWcnd4dUw3RE1LeVZfT3VxOHZjSnVzZDFVZmJad05MaXgtbWtQdGFZU2hZNn…

EXEL — Frequently Asked Questions

What is the current share price of EXEL?

As of 2026-08-05 17:25 PDT, EXEL trades at $56.70 on NASDAQ/NYSE. Its 52-week range is $34.54 to $57.10.

What is the P/E ratio of EXEL?

EXEL trades at a trailing price-to-earnings (P/E) ratio of 20.40.

What is the return on equity (ROE) of EXEL?

EXEL has a return on equity (ROE) of 36.21%. Its return on capital employed (ROCE) is 35.76%.

Is EXEL a good stock to buy?

This page provides a data-driven analysis of EXEL, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space